Loss of cortical GABA uptake sites in Alzheimer's disease
- PMID: 2833574
- DOI: 10.1007/BF01245715
Loss of cortical GABA uptake sites in Alzheimer's disease
Abstract
[3H]Nipecotic acid bound to membranes of human brain in a saturable, reversible manner which was totally dependent on the presence of sodium ions. The potencies of compounds in inhibiting the specific binding of [3H]nipecotic acid were closely correlated with their potencies in inhibiting the neuronal uptake of [3H]GABA. Compounds selective for GABA receptors were inactive. [3H]Nipecotic acid appears to label neuronal high affinity GABA uptake sites. The binding of [3H]nipecotic acid was substantially reduced in the temporal cortex of brains from subjects with Alzheimer-type dementia, but not in other brain regions. It is concluded that some loss of GABA terminals occurs in this disease.
Similar articles
-
[3H]nipecotic acid binding to GABA uptake sites in human brain.Brain Res. 1992 May 15;580(1-2):311-6. doi: 10.1016/0006-8993(92)90959-d. Brain Res. 1992. PMID: 1324088
-
Entropy as a factor in the binding of gamma-aminobutyric acid and nipecotic acid to the gamma-aminobutyric acid transport system.Neurochem Res. 1989 Apr;14(4):311-6. doi: 10.1007/BF01000032. Neurochem Res. 1989. PMID: 2548104
-
Ion dependency of uptake and release of GABA and (RS)-nipecotic acid studied in cultured mouse brain cortex neurons.J Neurosci Res. 1983;9(3):291-302. doi: 10.1002/jnr.490090306. J Neurosci Res. 1983. PMID: 6854668
-
[Nipecotic acid, a competitive inhibitor of the net uptake of 3H-GABA by rat brain synaptosomes].Biull Eksp Biol Med. 1981 Jun;91(6):692-4. Biull Eksp Biol Med. 1981. PMID: 7272486 Russian.
-
(R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier.J Neurochem. 1990 Feb;54(2):639-47. doi: 10.1111/j.1471-4159.1990.tb01919.x. J Neurochem. 1990. PMID: 2299358
Cited by
-
Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain.Exp Brain Res. 1989;77(3):611-20. doi: 10.1007/BF00249614. Exp Brain Res. 1989. PMID: 2572447
-
Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers.J Alzheimers Dis. 2020;78(4):1661-1678. doi: 10.3233/JAD-200716. J Alzheimers Dis. 2020. PMID: 33185603 Free PMC article.
-
Neuropharmacological correction of cognitive processes disrupted by extirpation of the AI-AII and Ep fields in cats.Neurosci Behav Physiol. 1996 Nov-Dec;26(6):558-64. doi: 10.1007/BF02359499. Neurosci Behav Physiol. 1996. PMID: 9121633
-
Impaired Expression of GABA Signaling Components in the Alzheimer's Disease Middle Temporal Gyrus.Int J Mol Sci. 2020 Nov 18;21(22):8704. doi: 10.3390/ijms21228704. Int J Mol Sci. 2020. PMID: 33218044 Free PMC article.
-
Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.Int J Mol Sci. 2017 Aug 21;18(8):1813. doi: 10.3390/ijms18081813. Int J Mol Sci. 2017. PMID: 28825683 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical